Canada · Delayed Price · Currency is CAD Altrova Health Statistics
Total Valuation
Altrova Health has a market cap or net worth of CAD 13.09 million. The enterprise value is 12.92 million.
| Market Cap | 13.09M |
| Enterprise Value | 12.92M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Altrova Health has 201.35 million shares outstanding. The number of shares has increased by 58.05% in one year.
| Current Share Class | 201.35M |
| Shares Outstanding | 201.35M |
| Shares Change (YoY) | +58.05% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 2.89% |
| Owned by Institutions (%) | n/a |
| Float | 195.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 103.95 |
| PB Ratio | 9.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 102.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -165.92% and return on invested capital (ROIC) is -43.97%.
| Return on Equity (ROE) | -165.92% |
| Return on Assets (ROA) | -31.44% |
| Return on Invested Capital (ROIC) | -43.97% |
| Return on Capital Employed (ROCE) | -165.75% |
| Weighted Average Cost of Capital (WACC) | -12.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.33% in the last 52 weeks. The beta is -3.07, so Altrova Health's price volatility has been lower than the market average.
| Beta (5Y) | -3.07 |
| 52-Week Price Change | +8.33% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 51.20 |
| Average Volume (20 Days) | 260,245 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Altrova Health had revenue of CAD 125,900 and -5.53 million in losses. Loss per share was -0.03.
| Revenue | 125,900 |
| Gross Profit | 34,954 |
| Operating Income | -2.35M |
| Pretax Income | -5.53M |
| Net Income | -5.53M |
| EBITDA | -2.30M |
| EBIT | -2.35M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 162,703 in cash and no debt, with a net cash position of 162,703 or 0.00 per share.
| Cash & Cash Equivalents | 162,703 |
| Total Debt | n/a |
| Net Cash | 162,703 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.41M |
| Book Value Per Share | 0.01 |
| Working Capital | -1.48M |
Cash Flow
| Operating Cash Flow | -668,210 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 41,108 |
| Net Borrowing | n/a |
| Free Cash Flow | -668,210 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 27.76% |
| Operating Margin | -1,862.70% |
| Pretax Margin | -4,393.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Altrova Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.05% |
| Shareholder Yield | -58.05% |
| Earnings Yield | -42.26% |
| FCF Yield | -5.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 3, 2023. It was a reverse split with a ratio of 0.25.
| Last Split Date | Oct 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Altrova Health has an Altman Z-Score of -6.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.63 |
| Piotroski F-Score | 2 |